Transgenic animals
AssigneeAstellas Pharma Inc.
InventorsAkira Miyake, Yukihiro Nakamura, Jianwei Ni, Shinobu Mochizuki
Life of this patent
Estimating the term…
Loading patent…
AssigneeAstellas Pharma Inc.
InventorsAkira Miyake, Yukihiro Nakamura, Jianwei Ni, Shinobu Mochizuki
Estimating the term…
There is discloses a transgenic mouse over-expressing a potassium channel BEC1, which can be used as an effective tool for screening a substance for antidementia or a substance to improve learning and memory. Also disclosed are an in vivo screening method of a substance for antidementia or a substance to improve learning and memory, which uses the learning and memory abilities of said mouse as the index, and an in vivo screening of a substance for antianxiety, which uses acceleration of anxiety as the index. In addition, there is disclosed a method for producing a pharmaceutical composition for antidementia, learning and memory improvement use or antianxiety, using a substance capable of inhibiting the learning and memory potassium channel activity as the active ingredient which can be obtained by the aforementioned screening method of the present invention.
A transgenic mouse whose genome comprises a transgene comprising a polynucleotide encoding a potassium channel polypeptide wherein said potassium channel polypeptide comprises the sequence set forth in SEQ ID NO:
Dependencies are inferred from the claim text.